DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mirtazapine (Mirtazapine) - Neuroleptic Malignant Syndrome - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Neuroleptic Malignant Syndrome (96)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mirtazapine where reactions include neuroleptic malignant syndrome. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 96   Next >>

Possible Mirtazapine side effects in 49 year old male

Reported by a consumer/non-health professional from France on 2012-08-23

Patient: 49 year old male

Reactions: Cytolytic Hepatitis, Neuroleptic Malignant Syndrome, Drug Withdrawal Syndrome

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Abilify
    Dosage: until jul12
    Administration route: Oral
    Indication: Schizophrenia

Alprazolam
    Administration route: Oral
    End date: 2012-07-01

Mianserin HCL
    End date: 2012-07-01

Mirtazapine
    Dosage: formulation: tabs
    Administration route: Oral



Possible Mirtazapine side effects in 51 year old male

Reported by a pharmacist from United Kingdom on 2012-08-13

Patient: 51 year old male

Reactions: Encephalopathy, Encephalitis, Neuroleptic Malignant Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine

Other drugs received by patient: Metformin Hydrochloride; Simvastatin; Glimepiride



Possible Mirtazapine side effects in

Reported by a pharmacist from Japan on 2012-08-10

Patient:

Reactions: Neuroleptic Malignant Syndrome

Drug(s) suspected as cause:
Mirtazapine



Possible Mirtazapine side effects in 51 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-09

Patient: 51 year old male

Reactions: Confusional State, Agitation, Blood Creatine Phosphokinase Increased, Encephalopathy, Encephalitis, Convulsion, Blood Lactic Acid Increased, CSF Protein Increased, Neuroleptic Malignant Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine

Other drugs received by patient: Simvastatin; Glimepiride; Metformin Hydrochloride



Possible Mirtazapine side effects in 51 year old male

Reported by a pharmacist from United Kingdom on 2012-08-09

Patient: 51 year old male

Reactions: Agitation, Confusional State, Encephalitis, Encephalopathy, Convulsion, Blood Lactic Acid Increased, CSF Protein Increased, Neuroleptic Malignant Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine

Other drugs received by patient: Glimepiride; Metformin Hydrochloride; Simvastatin



Possible Mirtazapine side effects in 51 year old male

Reported by a pharmacist on 2012-08-07

Patient: 51 year old male

Reactions: Confusional State, Agitation, Encephalitis, Encephalopathy, Neuroleptic Malignant Syndrome, Blood Lactic Acid Increased, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine

Other drugs received by patient: Glimepiride; Metfformin Hydrochloride; Simvastatin



Possible Mirtazapine side effects in 51 year old male

Reported by a pharmacist from United Kingdom on 2012-08-07

Patient: 51 year old male

Reactions: Agitation, Confusional State, Blood Creatine Phosphokinase Increased, Encephalitis, Encephalopathy, Convulsion, Blood Lactic Acid Increased, CSF Protein Increased, Neuroleptic Malignant Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine

Other drugs received by patient: Metformin Hydrochloride; Simvastatin; Glimepiride



Possible Mirtazapine side effects in

Reported by a pharmacist from United Kingdom on 2012-08-03

Patient:

Reactions: Confusional State, Agitation, Blood Creatine Phosphokinase Increased, Encephalitis, Encephalopathy, Blood Lactic Acid Increased, Convulsion, CSF Protein Increased, Neuroleptic Malignant Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine

Other drugs received by patient: Glimepiride; Simvastatin; Metformin Hydrochloride



Possible Mirtazapine side effects in male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-02

Patient: male

Reactions: Agitation, Confusional State, Encephalopathy, Encephalitis, Neuroleptic Malignant Syndrome, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine

Other drugs received by patient: Metformin Hydrochloride; Glimepiride; Simvastatin



Possible Mirtazapine side effects in 51 year old male

Reported by a pharmacist from United Kingdom on 2012-08-01

Patient: 51 year old male

Reactions: Agitation, Confusional State, Encephalopathy, Neuroleptic Malignant Syndrome, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine

Other drugs received by patient: Glimepiride; Metformin Hydrochloride; Simvastatin; Sertraline Hydrochloride



Possible Mirtazapine side effects in 51 year old male

Reported by a pharmacist on 2012-07-31

Patient: 51 year old male

Reactions: CSF Protein Increased, Encephalopathy, Encephalitis, Neuroleptic Malignant Syndrome, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine

Other drugs received by patient: Simvastatin; Glimepiride; Metfformin Hydrochloride



Possible Mirtazapine side effects in 51 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-24

Patient: 51 year old male

Reactions: Agitation, Confusional State, Blood Creatine Phosphokinase Increased, Encephalitis, Encephalopathy, Convulsion, Blood Lactic Acid Increased, CSF Protein Increased, Neuroleptic Malignant Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine

Other drugs received by patient: Glimepiride; Simvastatin; Metformin Hydrochloride



Possible Mirtazapine side effects in

Reported by a pharmacist from United Kingdom on 2012-07-24

Patient:

Reactions: Agitation, Confusional State, Blood Creatine Phosphokinase Increased, Encephalopathy, Encephalitis, Convulsion, Blood Lactic Acid Increased, CSF Protein Increased, Neuroleptic Malignant Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine

Other drugs received by patient: Glimepiride; Simvastatin; Metformin Hydrochloride



Possible Mirtazapine side effects in 51 year old male

Reported by a pharmacist from United Kingdom on 2012-07-23

Patient: 51 year old male

Reactions: Encephalitis, Encephalopathy, Neuroleptic Malignant Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine

Other drugs received by patient: Metformin Hydrochloride; Simvastatin; Glimepiride



Possible Mirtazapine side effects in 51 year old male

Reported by a pharmacist on 2012-07-20

Patient: 51 year old male

Reactions: Agitation, Confusional State, Encephalopathy, Encephalitis, Neuroleptic Malignant Syndrome, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine

Other drugs received by patient: Glimepiride; Simvastatin; Metfformin Hydrochloride



Possible Mirtazapine side effects in 51 year old male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-19

Patient: 51 year old male

Reactions: Confusional State, Agitation, Encephalitis, Neuroleptic Malignant Syndrome, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine

Other drugs received by patient: Simvastatin; Metformin Hydrochloride; Glimepiride



Possible Mirtazapine side effects in 51 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-14

Patient: 51 year old male

Reactions: Confusional State, Agitation, Encephalopathy, Neuroleptic Malignant Syndrome, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mirtazapine

Other drugs received by patient: Metformin Hydrochloride; Sertraline Hydrochloride; Simvastatin; Glimepiride



Possible Mirtazapine side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-06

Patient: female, weighing 103.0 kg (226.6 pounds)

Reactions: Osteosynthesis, Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Overdose, Myoglobin Blood Increased, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Renal Failure, Depressed Level of Consciousness, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1+0+0+1.5 (6 millimoles)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 80 mg
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Other drugs received by patient: Ferro Duretter; Centyl MED Kaliumklorid; Alprazolam



Possible Mirtazapine side effects in 72 year old female

Reported by a physician from Denmark on 2012-07-05

Patient: 72 year old female

Reactions: Rhabdomyolysis, Post Procedural Complication, Lactic Acidosis, Constipation, Fall, Liver Disorder, Multi-Organ Failure, Dialysis, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Polydipsia, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Cardiac Enzymes Increased, Lacunar Infarction, Hypertension, Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 6 mmol;unk;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg;bid;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Ferro Curetter; Kalimklorid; Centyl MED



Possible Mirtazapine side effects in female

Reported by a physician from Denmark on 2012-06-29

Patient: female

Reactions: Osteosynthesis, Humerus Fracture, Rhabdomyolysis, Dyspnoea, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Lacunar Infarction, Neuroleptic Malignant Syndrome, Hypertension, Cardiac Hypertrophy, Hepatic Cirrhosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, styrke: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Ferro Duretter; Centyl MED Kaliumklorid; Alprazolam



Possible Mirtazapine side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-28

Patient: female

Reactions: Humerus Fracture, Osteosynthesis, Dyspnoea, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Lacunar Infarction, Neuroleptic Malignant Syndrome, Hypertension, Cardiac Hypertrophy, Hepatic Cirrhosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 6 mmol, unk
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone HCL
    Dosage: 40 mg, bid
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Centyl MED Kaliumklorid; Fragmin; Ferro Duretter; Amlodipine Actavis; Alprazolam



Possible Mirtazapine side effects in 72 year old female

Reported by a physician from Denmark on 2012-06-26

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Humerus Fracture, Osteosynthesis, Rhabdomyolysis, Lactic Acidosis, Fall, Organ Failure, Multi-Organ Failure, Hyperventilation, Renal Failure, Lacunar Infarction, Depressed Level of Consciousness, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hepatic Cirrhosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Lithium Citrate
    Dosage: po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg;bid;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Other drugs received by patient: K CL TAB; Ferro Duretter; Alprazolam



Possible Mirtazapine side effects in female

Reported by a physician from Denmark on 2012-06-22

Patient: female

Reactions: Humerus Fracture, Osteosynthesis, Rhabdomyolysis, Dyspnoea, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Neuroleptic Malignant Syndrome, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cipralex
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, styrke: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Ferro Duretter; Centyl MED Kaliumklorid; Alprazolam



Possible Mirtazapine side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-22

Patient: female

Reactions: Confusional State, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Constipation, Hyperventilation, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Organ Failure, Renal Failure, Lacunar Infarction, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, qd (daily dose of 1 tablet in the morning and 1.5 tablet in the evening)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Escitalopram
    Dosage: 30 mg, qd
    Administration route: Oral
    End date: 2011-10-23

Lithium Citrate
    Administration route: Oral
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1.5 df (in the evening)
    Administration route: Oral
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1 df (in the morning)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, bid
    Administration route: Oral
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, bid
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Alprazolam; Centyl MED Kaliumklorid; Ferro Duretter



Possible Mirtazapine side effects in 72 year old female

Reported by a physician from Denmark on 2012-06-22

Patient: 72 year old female

Reactions: Confusional State, Rhabdomyolysis, Post Procedural Complication, Lactic Acidosis, Pyrexia, Serotonin Syndrome, Constipation, Fall, Hyperventilation, Multi-Organ Failure, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Hepatic Cirrhosis, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, General Physical Health Deterioration, Organ Failure, Depressed Level of Consciousness, Lacunar Infarction, Hypertension

Adverse event resulted in: death

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg, qd, po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 6 mmol, po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd, po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd, po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, bid, po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Ferro Duretter; Centyl MED; Kaliumklorid



Possible Mirtazapine side effects in 72 year old female

Reported by a physician from Denmark on 2012-06-22

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Confusional State, Osteosynthesis, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hepatic Cirrhosis, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Renal Failure, Depressed Level of Consciousness, Lacunar Infarction, Hypertension, Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, strength: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Centyl K; Ferro Duretter; Alprazolam



Possible Mirtazapine side effects in 72 year old female

Reported by a physician from Denmark on 2012-06-19

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Rhabdomyolysis, Serotonin Syndrome, Lactic Acidosis, Constipation, Fall, Dialysis, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Cardiac Enzymes Increased, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Lacunar Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Lithium Citrate
    Dosage: po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg;bid;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Other drugs received by patient: Ferro Duretter; Alprazolam; K CL TAB



Possible Mirtazapine side effects in female

Reported by a physician from Denmark on 2012-06-15

Patient: female

Reactions: Confusional State, Rhabdomyolysis, Pyrexia, Lactic Acidosis, Constipation, Fall, Hyperventilation, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Organ Failure, Renal Failure, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, qd (daily dose of 1 tablet in the morning and 1.5 tablet in the evening)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1 df (in the morning)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1.5 df (in the evening)
    Administration route: Oral
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: styrke: 40 mg
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Ferro Duretter; Centyl MED Kaliumklorid



Possible Mirtazapine side effects in 72 year old female

Reported by a physician from Denmark on 2012-06-11

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Osteosynthesis, Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Renal Failure, Depressed Level of Consciousness, Lacunar Infarction, Hypertension, Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, strength: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Fragmin; Ferro Duretter; Amlodipine; Centyl K; Furosemide



Possible Mirtazapine side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) on 2012-06-06

Patient: 44 year old female

Reactions: Bedridden, Confusional State, Psychomotor Retardation, Hyperthermia, Nuchal Rigidity, Serotonin Syndrome, Muscle Rigidity, Hyperhidrosis, Loss of Consciousness, Neuroleptic Malignant Syndrome, Blood Pressure Fluctuation, Hypertonia, Mobility Decreased

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Mirtazapine
    Dosage: 180 mg (45 mg, 4 in 1 d), oral
    Administration route: Oral
    Indication: Depression
    Start date: 2008-01-23
    End date: 2008-02-12

Risperidone
    Dosage: (62.5 mg, 1 wk)
    Indication: Bipolar Disorder
    Start date: 2007-11-02
    End date: 2008-01-24



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017